Folic acid and postmenopausal hot flashes
The hot-flash study result and the significance of the studied folic acid dose.
Key points
- In postmenopausal women over 12 weeks, folic acid did not show a convincing advantage over placebo on the combined score of hot-flash frequency and severity. The study did not establish a confirmed reduction in this measure. [1] See the evidence 1
- The studied 5 mg daily exceeds the US adult upper limit of 1,000 mcg of folic acid from supplements and fortified foods. Do not use the study dose as a self-directed regimen. [1] [2] See the evidence 1 2
Practical guide
Check the conclusions and whether they apply to your situation.
The study assessed hot-flash frequency and severity together.
Key points
Why these conclusions
The hot-flash study
Postmenopausal women with bothersome hot flashes received 5 mg of folic acid daily or placebo for 12 weeks. No convincing advantage was found on the composite score of hot-flash frequency and severity; certainty is very low. [1]
In the US, the tolerable upper intake level for adults is 1,000 mcg of folic acid daily from supplements and fortified foods. [2] [3]
In the US, the tolerable upper intake level of folic acid for adults aged 19 and older is 1,000 mcg daily from supplements and fortified foods; natural folate in ordinary food is not included. [2]
Folic acid can correct anemia in B12 deficiency while neurological consequences of the deficiency persist. [2]
In postmenopausal women, no convincing advantage was found on the composite score of hot-flash frequency and severity.
| Parameter | Data |
|---|---|
| Result | In postmenopausal women, no convincing advantage was found on the composite score of hot-flash frequency and severity. Composite hot-flash frequency and severity score: adjusted difference in change −2.61 points (95% CI −5.72 to +0.49), p=0.098; 143 of 164 randomized participants in the main analysis. |
| Participants | 164 postmenopausal women with bothersome hot flashes, 143 in the main comparison |
| Form | Oral folic acid |
| Dose | 5 mg daily |
| Dose basis | 5 mg daily |
| Comparator | Placebo |
| Duration | 12 weeks |
| Confidence | 1/4: Precision: The confidence interval allows both benefit and no effect. Consistency: A smaller trial found a different result. Applicability to the specified group: A specific dose and group of postmenopausal women with hot flashes were studied. Possible publication bias: Publication bias has not been established. Study methods: Data for 21 of 164 participants were unavailable for the main comparison. |
| Evidence base | 1 randomized trial |
| Sources | [1] |
In the US, the tolerable upper intake level for adults is 1,000 mcg of folic acid daily from supplements and fortified foods.
In the US, the tolerable upper intake level for adults is 1,000 mcg of folic acid daily from supplements and fortified foods. [2] [3]
In the US, the tolerable upper intake level of folic acid for adults aged 19 and older is 1,000 mcg daily from supplements and fortified foods; natural folate in ordinary food is not included.
In the US, the tolerable upper intake level of folic acid for adults aged 19 and older is 1,000 mcg daily from supplements and fortified foods; natural folate in ordinary food is not included. [2]
Folic acid can correct anemia in B12 deficiency while neurological consequences of the deficiency persist.
Folic acid can correct anemia in B12 deficiency while neurological consequences of the deficiency persist. [2]
Sources
- Folic acid supplementation in postmenopausal women with hot flushes: phase III randomised double-blind placebo-controlled trial. https://pubmed.ncbi.nlm.nih.gov/33982872/
- Folate - Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/Folate-HealthProfessional/
- Scientific opinion on the tolerable upper intake level for folate. https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2023.8353
Methodology: Subpages evidence-led supplement pipeline v1